ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
Apatinib as first-line treatment in patients with advanced hepatocellular carcinoma: a phase II clinical trial
Annals of Translational Medicine
◽
10.21037/atm-20-2990
◽
2020
◽
Vol 8
(17)
◽
pp. 1047-1047
Author(s):
Zhenyu Hou
◽
Keyun Zhu
◽
Xuejiao Yang
◽
Ping Chen
◽
Wei Zhang
◽
...
Keyword(s):
Hepatocellular Carcinoma
◽
Clinical Trial
◽
Phase Ii
◽
Phase Ii Clinical Trial
◽
Advanced Hepatocellular Carcinoma
◽
Line Treatment
◽
First Line
◽
First Line Treatment
Download Full-text
Related Documents
Cited By
References
Randomized, Open, Prospective, Phase II Clinical Trial of Doxorubicin (DOXO) vs. Trabectedin Plus Doxo in the First-Line Treatment of Patients (PTS) with Advanced Non-Operable and/or Metastatic Soft Tissue Sarcomas (STS): Geis-20 Study
Annals of Oncology
◽
10.1016/s0923-7534(20)34065-5
◽
2012
◽
Vol 23
◽
pp. ix490
◽
Cited By ~ 1
Author(s):
J. Martin Broto
◽
X. Garcia Del Muro
◽
A. Lopez-Pousa
◽
R. Las De Penas
◽
J. Maurel
◽
...
Keyword(s):
Clinical Trial
◽
Soft Tissue
◽
Phase Ii
◽
Soft Tissue Sarcomas
◽
Phase Ii Clinical Trial
◽
Line Treatment
◽
First Line
◽
Prospective Phase
◽
First Line Treatment
Download Full-text
Chemotherapy with or without autologous cytokine-induced killer cell transfusion as the first-line treatment for stage IV gastrointestinal cancer: a phase II clinical trial
Journal of Cancer Research and Clinical Oncology
◽
10.1007/s00432-016-2127-2
◽
2016
◽
Vol 142
(6)
◽
pp. 1315-1323
◽
Cited By ~ 2
Author(s):
Ying-Chun Xu
◽
Qi Xu
◽
Jun-Jian Li
◽
Xiao-Feng Gu
◽
Xiao-Lin Lin
◽
...
Keyword(s):
Clinical Trial
◽
Phase Ii
◽
Gastrointestinal Cancer
◽
Killer Cell
◽
Stage Iv
◽
Phase Ii Clinical Trial
◽
Line Treatment
◽
First Line
◽
First Line Treatment
Download Full-text
1404P Update results of paclitaxel and cisplatin in combination with anlotinib as first-line treatment for patients with advanced ESCC: A multicenter, single-arm, open-label phase II clinical trial
Annals of Oncology
◽
10.1016/j.annonc.2021.08.1513
◽
2021
◽
Vol 32
◽
pp. S1058
Author(s):
J. Wang
◽
T. Wu
◽
Y-G. Hong
◽
S-X. Luo
◽
N. Li
◽
...
Keyword(s):
Clinical Trial
◽
Phase Ii
◽
Phase Ii Clinical Trial
◽
Line Treatment
◽
First Line
◽
Open Label
◽
Open Label Phase
◽
First Line Treatment
Download Full-text
56P Anti-PD1 antibody toripalimab, lenvatinib and gemox chemotherapy as first-line treatment of advanced and unresectable intrahepatic cholangiocarcinoma: A phase II clinical trial
Annals of Oncology
◽
10.1016/j.annonc.2020.08.034
◽
2020
◽
Vol 31
◽
pp. S262-S263
Author(s):
J. Zhou
◽
J. Fan
◽
G. Shi
◽
X. Huang
◽
D. Wu
◽
...
Keyword(s):
Clinical Trial
◽
Phase Ii
◽
Intrahepatic Cholangiocarcinoma
◽
Phase Ii Clinical Trial
◽
Line Treatment
◽
First Line
◽
First Line Treatment
Download Full-text
A Randomized Phase II Open-Label Multi-Institution Study of the Combination of Bevacizumab and Erlotinib Compared to Sorafenib in the First-Line Treatment of Patients with Advanced Hepatocellular Carcinoma
Oncology
◽
10.1159/000485384
◽
2018
◽
Vol 94
(6)
◽
pp. 329-339
◽
Cited By ~ 7
Author(s):
Melanie B. Thomas
◽
Elizabeth Garrett-Mayer
◽
Munazza Anis
◽
Kate Anderton
◽
Tricia Bentz
◽
...
Keyword(s):
Hepatocellular Carcinoma
◽
Phase Ii
◽
Advanced Hepatocellular Carcinoma
◽
Line Treatment
◽
First Line
◽
Open Label
◽
Randomized Phase Ii
◽
First Line Treatment
Download Full-text
Phase II clinical trial using camrelizumab combined with apatinib and chemotherapy as the first‐line treatment of advanced esophageal squamous cell carcinoma
Cancer Communications
◽
10.1002/cac2.12119
◽
2020
◽
Vol 40
(12)
◽
pp. 711-720
Author(s):
Bo Zhang
◽
Ling Qi
◽
Xi Wang
◽
Jianping Xu
◽
Yun Liu
◽
...
Keyword(s):
Clinical Trial
◽
Squamous Cell Carcinoma
◽
Esophageal Squamous Cell Carcinoma
◽
Cell Carcinoma
◽
Phase Ii
◽
Squamous Cell
◽
Phase Ii Clinical Trial
◽
Line Treatment
◽
First Line
◽
First Line Treatment
Download Full-text
1131 POSTER Addition of CPG 7909 to taxane/platinum regimen for first-line treatment of unresectable NSCLC improves objective response in phase II clinical trial
European Journal of Cancer Supplements
◽
10.1016/s1359-6349(05)81425-9
◽
2005
◽
Vol 3
(2)
◽
pp. 326-327
◽
Cited By ~ 1
Keyword(s):
Clinical Trial
◽
Phase Ii
◽
Objective Response
◽
Phase Ii Clinical Trial
◽
Line Treatment
◽
First Line
◽
First Line Treatment
Download Full-text
A phase II clinical trial of ZD1839 (Iressa™) in combination with docetaxel as first-line treatment in patients with advanced breast cancer
Investigational New Drugs
◽
10.1007/s10637-007-9055-6
◽
2007
◽
Vol 25
(6)
◽
pp. 545-551
◽
Cited By ~ 15
Author(s):
Sheri K. Dennison
◽
Samuel A. Jacobs
◽
John W. Wilson
◽
Janell Seeger
◽
Terrence P. Cescon
◽
...
Keyword(s):
Breast Cancer
◽
Clinical Trial
◽
Advanced Breast Cancer
◽
Phase Ii
◽
Phase Ii Clinical Trial
◽
Advanced Breast
◽
Line Treatment
◽
First Line
◽
First Line Treatment
Download Full-text
935P An exploratory subgroup analysis of a phase II/III trial of donafenib versus sorafenib in the first-line treatment of advanced hepatocellular carcinoma
Annals of Oncology
◽
10.1016/j.annonc.2021.08.155
◽
2021
◽
Vol 32
◽
pp. S820
Author(s):
F. Bi
◽
S. Qin
◽
S. Gu
◽
Y. Bai
◽
Z. Chen
◽
...
Keyword(s):
Hepatocellular Carcinoma
◽
Phase Ii
◽
Subgroup Analysis
◽
Advanced Hepatocellular Carcinoma
◽
Line Treatment
◽
First Line
◽
First Line Treatment
Download Full-text
424P Update results from ALTER-C-001 study: Efficacy and safety of anlotinib plus XELOX regimen as first-line treatment followed by maintenance monotherapy of anlotinib for patients with mCRC: A single arm, multi-center, phase II clinical trial
Annals of Oncology
◽
10.1016/j.annonc.2021.08.945
◽
2021
◽
Vol 32
◽
pp. S546-S547
Author(s):
Y. Jin
◽
Y. Han
◽
L. Zhang
◽
Y. Jin
◽
H. Sun
Keyword(s):
Clinical Trial
◽
Phase Ii
◽
Phase Ii Clinical Trial
◽
Line Treatment
◽
Efficacy And Safety
◽
First Line
◽
First Line Treatment
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close